25 XP   0   0   10

Cryosite Ltd
Buy, Hold or Sell?

Let's analyse Cryosite together

PenkeI guess you are interested in Cryosite Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Cryosite Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Cryosite Ltd

I send you an email if I find something interesting about Cryosite Ltd.

Quick analysis of Cryosite (30 sec.)










What can you expect buying and holding a share of Cryosite? (30 sec.)

How much money do you get?

How much money do you get?
A$0.03
When do you have the money?
1 year
How often do you get paid?
80.0%

What is your share worth?

Current worth
A$0.06
Expected worth in 1 year
A$0.13
How sure are you?
70.0%

+ What do you gain per year?

Total Gains per Share
A$0.12
Return On Investment
18.0%

For what price can you sell your share?

Current Price per Share
A$0.64
Expected price per share
A$0.64 - A$0.7556
How sure are you?
50%

1. Valuation of Cryosite (5 min.)




Live pricePrice per Share (EOD)

A$0.64

Intrinsic Value Per Share

A$0.05 - A$0.45

Total Value Per Share

A$0.11 - A$0.51

2. Growth of Cryosite (5 min.)




Is Cryosite growing?

Current yearPrevious yearGrowGrow %
How rich?$1.7m$1.2m$595.6k33.1%

How much money is Cryosite making?

Current yearPrevious yearGrowGrow %
Making money$911.2k$881.9k$29.2k3.2%
Net Profit Margin11.8%11.6%--

How much money comes from the company's main activities?

3. Financial Health of Cryosite (5 min.)




4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  

What can you expect buying and holding a share of Cryosite? (5 min.)

Welcome investor! Cryosite's management wants to use your money to grow the business. In return you get a share of Cryosite.

What can you expect buying and holding a share of Cryosite?

First you should know what it really means to hold a share of Cryosite. And how you can make/lose money.

Speculation

The Price per Share of Cryosite is A$0.64. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Cryosite.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Cryosite, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.06. Based on the TTM, the Book Value Change Per Share is A$0.02 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.02 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.01 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Cryosite.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps0.022.9%0.022.9%0.022.8%0.011.8%0.010.9%
Usd Book Value Change Per Share0.011.9%0.011.9%0.012.2%0.000.3%0.00-0.7%
Usd Dividend Per Share0.011.0%0.011.0%0.011.0%0.010.8%0.010.9%
Usd Total Gains Per Share0.022.9%0.022.9%0.023.2%0.011.2%0.000.2%
Usd Price Per Share0.40-0.40-0.41-0.24-0.19-
Price to Earnings Ratio21.65-21.65-22.55-14.82-21.14-
Price-to-Total Gains Ratio21.65-21.65-20.10-12.14-14.36-
Price to Book Ratio10.97-10.97-16.52-18.17-10.63-
Price-to-Total Gains Ratio21.65-21.65-20.10-12.14-14.36-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.413888
Number of shares2416
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.01
Usd Book Value Change Per Share0.010.00
Usd Total Gains Per Share0.020.01
Gains per Quarter (2416 shares)45.1117.87
Gains per Year (2416 shares)180.4271.46
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
162118170502161
212523635010043132
318735453015064203
425047271020086274
5312590890250107345
63757081070300129416
74378261250350150487
85009431430400172558
956210611610450193629
1062511791790500215700

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%8.02.00.080.0%16.07.00.069.6%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%4.06.00.040.0%15.08.00.065.2%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%4.00.01.080.0%8.00.02.080.0%10.00.013.043.5%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%7.03.00.070.0%18.05.00.078.3%

Fundamentals of Cryosite

About Cryosite Ltd

Cryosite Limited offers outsourced clinical trials logistic services in Australia. It operates through two segments, Clinical Trials and Biological Services Logistics, and Cord Blood and Tissues Storage. The Clinical Trials and Biological Services Logistics segment provides specialist temperature-controlled storage, sourcing, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns and biological, as well as logistics services to the clinical trials, research, and pharmaceutical industries. The Cord Blood and Tissues Storage segment offers long term storage solutions for cord blood and tissue samples. It serves research, medical, pharmaceutical, and biotechnology industries. The company was incorporated in 1999 and is based in South Granville, Australia.

Fundamental data was last updated by Penke on 2024-04-10 02:11:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is very efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is underpriced.

1.1. Profitability of Cryosite Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Cryosite earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Cryosite to the Diagnostics & Research industry mean.
  • A Net Profit Margin of 11.8% means that $0.12 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Cryosite Ltd:

  • The MRQ is 11.8%. The company is making a huge profit. +2
  • The TTM is 11.8%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ11.8%TTM11.8%0.0%
TTM11.8%YOY11.6%+0.2%
TTM11.8%5Y7.9%+3.9%
5Y7.9%10Y3.4%+4.5%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ11.8%-7.2%+19.0%
TTM11.8%-5.3%+17.1%
YOY11.6%0.9%+10.7%
5Y7.9%-3.4%+11.3%
10Y3.4%-1.4%+4.8%
1.1.2. Return on Assets

Shows how efficient Cryosite is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Cryosite to the Diagnostics & Research industry mean.
  • 6.2% Return on Assets means that Cryosite generated $0.06 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Cryosite Ltd:

  • The MRQ is 6.2%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 6.2%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ6.2%TTM6.2%0.0%
TTM6.2%YOY6.3%-0.1%
TTM6.2%5Y3.9%+2.3%
5Y3.9%10Y1.8%+2.1%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ6.2%-1.8%+8.0%
TTM6.2%-1.3%+7.5%
YOY6.3%-0.4%+6.7%
5Y3.9%-0.6%+4.5%
10Y1.8%-1.3%+3.1%
1.1.3. Return on Equity

Shows how efficient Cryosite is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Cryosite to the Diagnostics & Research industry mean.
  • 50.6% Return on Equity means Cryosite generated $0.51 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Cryosite Ltd:

  • The MRQ is 50.6%. Using its investors money, the company is very efficient in making profit. +2
  • The TTM is 50.6%. Using its investors money, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ50.6%TTM50.6%0.0%
TTM50.6%YOY73.3%-22.6%
TTM50.6%5Y231.9%-181.2%
5Y231.9%10Y113.3%+118.6%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ50.6%-1.2%+51.8%
TTM50.6%-0.1%+50.7%
YOY73.3%0.4%+72.9%
5Y231.9%-1.7%+233.6%
10Y113.3%-2.5%+115.8%

1.2. Operating Efficiency of Cryosite Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Cryosite is operating .

  • Measures how much profit Cryosite makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Cryosite to the Diagnostics & Research industry mean.
  • An Operating Margin of 12.8% means the company generated $0.13  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Cryosite Ltd:

  • The MRQ is 12.8%. The company is operating less efficient.
  • The TTM is 12.8%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ12.8%TTM12.8%0.0%
TTM12.8%YOY16.1%-3.3%
TTM12.8%5Y10.3%+2.5%
5Y10.3%10Y5.8%+4.5%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ12.8%-4.3%+17.1%
TTM12.8%-2.3%+15.1%
YOY16.1%4.8%+11.3%
5Y10.3%2.3%+8.0%
10Y5.8%-1.3%+7.1%
1.2.2. Operating Ratio

Measures how efficient Cryosite is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 0.87 means that the operating costs are $0.87 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Cryosite Ltd:

  • The MRQ is 0.872. The company is less efficient in keeping operating costs low.
  • The TTM is 0.872. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.872TTM0.8720.000
TTM0.872YOY0.839+0.033
TTM0.8725Y0.906-0.033
5Y0.90610Y0.972-0.067
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8721.302-0.430
TTM0.8721.300-0.428
YOY0.8391.236-0.397
5Y0.9061.261-0.355
10Y0.9721.238-0.266

1.3. Liquidity of Cryosite Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Cryosite is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 2.11 means the company has $2.11 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Cryosite Ltd:

  • The MRQ is 2.114. The company is able to pay all its short-term debts. +1
  • The TTM is 2.114. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.114TTM2.1140.000
TTM2.114YOY1.892+0.222
TTM2.1145Y1.893+0.221
5Y1.89310Y3.045-1.152
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ2.1142.194-0.080
TTM2.1142.366-0.252
YOY1.8922.822-0.930
5Y1.8933.017-1.124
10Y3.0453.000+0.045
1.3.2. Quick Ratio

Measures if Cryosite is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Cryosite to the Diagnostics & Research industry mean.
  • A Quick Ratio of 2.24 means the company can pay off $2.24 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Cryosite Ltd:

  • The MRQ is 2.239. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.239. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.239TTM2.2390.000
TTM2.239YOY1.759+0.480
TTM2.2395Y1.740+0.500
5Y1.74010Y2.877-1.137
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ2.2391.355+0.884
TTM2.2391.366+0.873
YOY1.7591.563+0.196
5Y1.7401.997-0.257
10Y2.8772.127+0.750

1.4. Solvency of Cryosite Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Cryosite assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Cryosite to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.88 means that Cryosite assets are financed with 87.7% credit (debt) and the remaining percentage (100% - 87.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Cryosite Ltd:

  • The MRQ is 0.877. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.877. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.877TTM0.8770.000
TTM0.877YOY0.913-0.036
TTM0.8775Y0.964-0.087
5Y0.96410Y0.798+0.166
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8770.425+0.452
TTM0.8770.416+0.461
YOY0.9130.393+0.520
5Y0.9640.450+0.514
10Y0.7980.448+0.350
1.4.2. Debt to Equity Ratio

Measures if Cryosite is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Cryosite to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 714.1% means that company has $7.14 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Cryosite Ltd:

  • The MRQ is 7.141. The company is unable to pay all its debts with equity. -1
  • The TTM is 7.141. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ7.141TTM7.1410.000
TTM7.141YOY10.555-3.414
TTM7.1415Y38.858-31.717
5Y38.85810Y20.372+18.485
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ7.1410.606+6.535
TTM7.1410.574+6.567
YOY10.5550.603+9.952
5Y38.8580.648+38.210
10Y20.3720.730+19.642

2. Market Valuation of Cryosite Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Cryosite generates.

  • Above 15 is considered overpriced but always compare Cryosite to the Diagnostics & Research industry mean.
  • A PE ratio of 21.65 means the investor is paying $21.65 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Cryosite Ltd:

  • The EOD is 22.170. Based on the earnings, the company is fair priced.
  • The MRQ is 21.651. Based on the earnings, the company is fair priced.
  • The TTM is 21.651. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD22.170MRQ21.651+0.520
MRQ21.651TTM21.6510.000
TTM21.651YOY22.547-0.896
TTM21.6515Y14.817+6.834
5Y14.81710Y21.138-6.321
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD22.170-0.295+22.465
MRQ21.651-0.518+22.169
TTM21.651-0.156+21.807
YOY22.547-0.003+22.550
5Y14.8171.627+13.190
10Y21.1386.427+14.711
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Cryosite Ltd:

  • The EOD is 28.219. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 27.557. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 27.557. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD28.219MRQ27.557+0.661
MRQ27.557TTM27.5570.000
TTM27.557YOY18.846+8.712
TTM27.5575Y42.586-15.028
5Y42.58610Y9.221+33.364
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD28.219-0.284+28.503
MRQ27.557-0.382+27.939
TTM27.557-1.074+28.631
YOY18.846-2.055+20.901
5Y42.586-2.492+45.078
10Y9.221-2.411+11.632
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Cryosite is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 10.97 means the investor is paying $10.97 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Cryosite Ltd:

  • The EOD is 11.229. Based on the equity, the company is expensive. -2
  • The MRQ is 10.965. Based on the equity, the company is expensive. -2
  • The TTM is 10.965. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD11.229MRQ10.965+0.263
MRQ10.965TTM10.9650.000
TTM10.965YOY16.524-5.558
TTM10.9655Y18.174-7.208
5Y18.17410Y10.633+7.541
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD11.2291.960+9.269
MRQ10.9652.449+8.516
TTM10.9652.225+8.740
YOY16.5243.239+13.285
5Y18.1743.393+14.781
10Y10.6333.897+6.736
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Cryosite Ltd.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Cryosite Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0190.0190%0.021-12%0.003+449%-0.007+138%
Book Value Per Share--0.0570.0570%0.038+49%0.016+257%0.045+26%
Current Ratio--2.1142.1140%1.892+12%1.893+12%3.045-31%
Debt To Asset Ratio--0.8770.8770%0.913-4%0.964-9%0.798+10%
Debt To Equity Ratio--7.1417.1410%10.555-32%38.858-82%20.372-65%
Dividend Per Share--0.0100.0100%0.0100%0.008+25%0.009+14%
Eps--0.0290.0290%0.028+3%0.018+62%0.009+207%
Free Cash Flow Per Share--0.0230.0230%0.033-32%0.013+74%0.012+95%
Free Cash Flow To Equity Per Share--0.0060.0060%0.030-79%0.006+5%-0.001+114%
Gross Profit Margin--0.9610.9610%0.936+3%1.092-12%0.372+159%
Intrinsic Value_10Y_max--0.449--------
Intrinsic Value_10Y_min--0.051--------
Intrinsic Value_1Y_max--0.025--------
Intrinsic Value_1Y_min--0.010--------
Intrinsic Value_3Y_max--0.090--------
Intrinsic Value_3Y_min--0.026--------
Intrinsic Value_5Y_max--0.174--------
Intrinsic Value_5Y_min--0.038--------
Market Cap31238144.000+2%30506000.00030506000.0000%30750048.000-1%17913123.200+70%14667284.800+108%
Net Profit Margin--0.1180.1180%0.116+2%0.079+50%0.034+249%
Operating Margin--0.1280.1280%0.161-21%0.103+24%0.058+122%
Operating Ratio--0.8720.8720%0.839+4%0.906-4%0.972-10%
Pb Ratio11.229+2%10.96510.9650%16.524-34%18.174-40%10.633+3%
Pe Ratio22.170+2%21.65121.6510%22.547-4%14.817+46%21.138+2%
Price Per Share0.640+2%0.6250.6250%0.630-1%0.367+70%0.301+108%
Price To Free Cash Flow Ratio28.219+2%27.55727.5570%18.846+46%42.586-35%9.221+199%
Price To Total Gains Ratio22.169+2%21.65021.6500%20.102+8%12.143+78%14.362+51%
Quick Ratio--2.2392.2390%1.759+27%1.740+29%2.877-22%
Return On Assets--0.0620.0620%0.063-2%0.039+60%0.018+243%
Return On Equity--0.5060.5060%0.733-31%2.319-78%1.133-55%
Total Gains Per Share--0.0290.0290%0.031-8%0.011+152%0.002+1639%
Usd Book Value--1799119.4001799119.4000%1203467.958+49%504551.072+257%1426029.440+26%
Usd Book Value Change Per Share--0.0120.0120%0.014-12%0.002+449%-0.005+138%
Usd Book Value Per Share--0.0370.0370%0.025+49%0.010+257%0.029+26%
Usd Dividend Per Share--0.0060.0060%0.0060%0.005+25%0.006+14%
Usd Eps--0.0190.0190%0.018+3%0.012+62%0.006+207%
Usd Free Cash Flow--715896.900715896.9000%1055211.336-32%412482.980+74%366196.850+95%
Usd Free Cash Flow Per Share--0.0150.0150%0.022-32%0.008+74%0.008+95%
Usd Free Cash Flow To Equity Per Share--0.0040.0040%0.020-79%0.004+5%-0.001+114%
Usd Market Cap20201707.725+2%19728230.20019728230.2000%19886056.042-1%11584416.773+70%9485333.080+108%
Usd Price Per Share0.414+2%0.4040.4040%0.407-1%0.237+70%0.194+108%
Usd Profit--911200.300911200.3000%881989.508+3%561390.828+62%296727.042+207%
Usd Revenue--7718364.5007718364.5000%7603154.895+2%6537769.674+18%6131631.598+26%
Usd Total Gains Per Share--0.0190.0190%0.020-8%0.007+152%0.001+1639%
 EOD+4 -4MRQTTM+0 -0YOY+17 -175Y+32 -410Y+28 -8

4.2. Fundamental Score

Let's check the fundamental score of Cryosite Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1522.170
Price to Book Ratio (EOD)Between0-111.229
Net Profit Margin (MRQ)Greater than00.118
Operating Margin (MRQ)Greater than00.128
Quick Ratio (MRQ)Greater than12.239
Current Ratio (MRQ)Greater than12.114
Debt to Asset Ratio (MRQ)Less than10.877
Debt to Equity Ratio (MRQ)Less than17.141
Return on Equity (MRQ)Greater than0.150.506
Return on Assets (MRQ)Greater than0.050.062
Total7/10 (70.0%)

4.3. Technical Score

Let's check the technical score of Cryosite Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5037.494
Ma 20Greater thanMa 500.671
Ma 50Greater thanMa 1000.643
Ma 100Greater thanMa 2000.615
OpenGreater thanClose0.640
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets22,647
Total Liabilities19,865
Total Stockholder Equity2,782
 As reported
Total Liabilities 19,865
Total Stockholder Equity+ 2,782
Total Assets = 22,647

Assets

Total Assets22,647
Total Current Assets7,986
Long-term Assets14,661
Total Current Assets
Cash And Cash Equivalents 4,731
Short-term Investments 1,000
Net Receivables 1,727
Inventory 60
Other Current Assets 468
Total Current Assets  (as reported)7,986
Total Current Assets  (calculated)7,986
+/-0
Long-term Assets
Property Plant Equipment 4,036
Intangible Assets 8
Long-term Assets Other 9,558
Long-term Assets  (as reported)14,661
Long-term Assets  (calculated)13,602
+/- 1,059

Liabilities & Shareholders' Equity

Total Current Liabilities3,777
Long-term Liabilities16,088
Total Stockholder Equity2,782
Total Current Liabilities
Short-term Debt 161
Accounts payable 632
Other Current Liabilities 944
Total Current Liabilities  (as reported)3,777
Total Current Liabilities  (calculated)1,737
+/- 2,040
Long-term Liabilities
Long term Debt Total 2,445
Capital Lease Obligations Min Short Term Debt2,445
Other Liabilities 13,643
Long-term Liabilities  (as reported)16,088
Long-term Liabilities  (calculated)18,533
+/- 2,445
Total Stockholder Equity
Common Stock5,979
Retained Earnings -3,197
Total Stockholder Equity (as reported)2,782
Total Stockholder Equity (calculated)2,782
+/-0
Other
Capital Stock5,979
Cash And Equivalents5,731
Cash and Short Term Investments 5,731
Common Stock Shares Outstanding 48,810
Current Deferred Revenue2,040
Liabilities and Stockholders Equity 22,647
Net Debt -2,125
Net Invested Capital 2,782
Net Tangible Assets 2,678
Net Working Capital 5,404
Property Plant and Equipment Gross 8,186
Short Long Term Debt Total 2,606



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-302002-06-302001-06-30
> Total Assets 
4,048
4,359
3,525
4,403
4,661
5,114
6,398
7,249
7,355
7,682
8,625
9,770
11,362
11,633
9,123
9,657
9,827
7,744
23,172
23,502
21,993
21,503
22,647
22,64721,50321,99323,50223,1727,7449,8279,6579,12311,63311,3629,7708,6257,6827,3557,2496,3985,1144,6614,4033,5254,3594,048
   > Total Current Assets 
2,848
3,232
2,264
2,811
2,282
2,540
3,132
3,830
3,030
3,306
4,348
5,993
7,860
8,356
6,266
6,938
7,613
6,382
6,947
5,594
5,997
7,051
7,986
7,9867,0515,9975,5946,9476,3827,6136,9386,2668,3567,8605,9934,3483,3063,0303,8303,1322,5402,2822,8112,2643,2322,848
       Cash And Cash Equivalents 
2,754
2,898
1,635
2,076
1,348
1,302
1,582
1,975
1,327
2,045
2,911
4,525
5,777
6,252
4,167
3,652
5,089
4,688
3,920
4,062
3,881
5,341
4,731
4,7315,3413,8814,0623,9204,6885,0893,6524,1676,2525,7774,5252,9112,0451,3271,9751,5821,3021,3482,0761,6352,8982,754
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
324
0
0
0
1,000
1,000000324000000000000000000
       Net Receivables 
70
281
513
567
774
1,073
1,335
1,678
1,403
1,171
1,246
1,157
1,639
1,897
1,752
2,876
2,310
1,359
838
963
1,670
1,213
1,727
1,7271,2131,6709638381,3592,3102,8761,7521,8971,6391,1571,2461,1711,4031,6781,3351,07377456751328170
       Inventory 
2
7
20
17
24
27
28
49
53
46
28
53
66
62
90
120
82
24
23
48
53
47
60
604753482324821209062665328465349282724172072
       Other Current Assets 
21
46
96
151
136
138
188
128
247
44
163
258
378
144
256
290
132
311
1,533
522
393
450
468
4684503935221,53331113229025614437825816344247128188138136151964621
   > Long-term Assets 
1,200
1,127
1,260
1,592
2,379
2,574
3,265
3,419
4,324
4,377
4,277
3,777
3,502
3,278
2,857
2,720
2,214
1,362
16,225
17,908
15,996
14,452
14,661
14,66114,45215,99617,90816,2251,3622,2142,7202,8573,2783,5023,7774,2774,3774,3243,4193,2652,5742,3791,5921,2601,1271,200
       Property Plant Equipment 
1,161
1,097
1,143
1,050
1,196
887
817
937
2,010
2,188
2,377
1,996
1,793
1,623
1,457
1,206
919
623
387
2,382
2,149
2,404
4,036
4,0362,4042,1492,3823876239191,2061,4571,6231,7931,9962,3772,1882,0109378178871,1961,0501,1431,0971,161
       Intangible Assets 
9
410
0
0
0
50
348
279
0
0
142
124
72
255
390
564
559
57
7
20
16
12
8
81216207575595643902557212414200279348500004109
       Long-term Assets Other 
31
31
118
541
1,183
1,637
1,552
1,474
1,551
1,435
1,117
998
857
796
561
637
532
533
13,232
13,232
12,083
10,776
9,558
9,55810,77612,08313,23213,2325335326375617968579981,1171,4351,5511,4741,5521,6371,1835411183131
> Total Liabilities 
180
469
755
1,364
2,183
2,301
2,662
2,927
3,014
3,328
3,934
4,290
5,098
5,498
5,578
6,279
6,678
5,800
24,888
23,347
21,174
19,642
19,865
19,86519,64221,17423,34724,8885,8006,6786,2795,5785,4985,0984,2903,9343,3283,0142,9272,6622,3012,1831,364755469180
   > Total Current Liabilities 
177
468
503
760
994
731
1,194
1,410
1,493
1,416
1,770
1,757
2,067
1,935
1,762
1,960
1,911
1,142
3,354
3,366
3,478
3,726
3,777
3,7773,7263,4783,3663,3541,1421,9111,9601,7621,9352,0671,7571,7701,4161,4931,4101,194731994760503468177
       Short-term Debt 
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
793
197
215
233
161
161233215197793000000000000000100
       Accounts payable 
9
130
240
308
264
393
440
476
459
328
434
437
722
482
298
450
387
163
240
389
627
460
632
6324606273892401633874502984827224374343284594764403932643082401309
       Other Current Liabilities 
23
251
231
337
540
247
494
657
748
774
998
984
978
1,061
1,117
1,139
1,130
553
47
571
449
800
944
944800449571475531,1301,1391,1171,06197898499877474865749424754033723125123
   > Long-term Liabilities 
3
1
251
604
1,189
1,569
1,467
1,517
1,521
1,912
2,164
2,533
3,031
3,563
3,817
4,319
4,767
4,659
21,534
19,981
17,696
15,916
16,088
16,08815,91617,69619,98121,5344,6594,7674,3193,8173,5633,0312,5332,1641,9121,5211,5171,4671,5691,18960425113
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,065
850
616
2,445
2,4456168501,0650000000000000000000
       Long term Debt 
5
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000015
       Capital Lease Obligations Min Short Term Debt
0
0
-1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-793
1,065
850
616
2,445
2,4456168501,065-793000000000000000-100
       Other Liabilities 
0
0
251
604
1,189
1,570
1,467
1,517
1,520
1,912
2,164
2,533
3,030
3,563
3,817
4,319
4,767
4,659
21,534
19,358
17,288
15,299
13,643
13,64315,29917,28819,35821,5344,6594,7674,3193,8173,5633,0302,5332,1641,9121,5201,5171,4671,5701,18960425100
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
578
528
475
418
358
358418475528578000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13,232
11,900
10,604
9,351
8,156
8,1569,35110,60411,90013,232000000000000000000
> Total Stockholder Equity
3,868
3,890
2,770
3,039
2,478
2,813
3,736
4,321
4,340
4,355
4,691
5,481
6,264
6,135
3,544
3,378
3,149
1,943
-1,716
155
819
1,861
2,782
2,7821,861819155-1,7161,9433,1493,3783,5446,1356,2645,4814,6914,3554,3404,3213,7362,8132,4783,0392,7703,8903,868
   Common Stock
5,875
6,631
6,681
7,816
7,816
8,036
8,036
8,139
8,139
8,139
8,139
8,139
8,139
8,205
5,862
5,862
5,862
5,862
5,862
5,862
5,862
5,979
5,979
5,9795,9795,8625,8625,8625,8625,8625,8625,8628,2058,1398,1398,1398,1398,1398,1398,0368,0367,8167,8166,6816,6315,875
   Retained Earnings -3,197-4,118-5,515-6,167-7,647-3,959-2,718-2,483-2,556-2,309-2,114-2,897-3,687-4,021-4,025-4,033-4,480-5,402-5,481-4,861-3,911-2,741-2,006
   Accumulated Other Comprehensive Income 
-154
-277
-528
84
143
180
180
215
227
237
239
239
239
239
239
-3,370
5
40
70
460
472
0
0
0047246070405-3,37023923923923923923722721518018014384-528-277-154
   Capital Surplus 00000000000000000000000
   Treasury Stock00000000000000000000000
   Other Stockholders Equity 
154
277
0
0
0
0
0
0
0
0
0
0
0
239
239
0
5
40
70
19
-347
0
-2,782
-2,7820-3471970405023923900000000000277154



Balance Sheet

Currency in AUD. All numbers in thousands.




Cash Flow

Currency in AUD. All numbers in thousands.